Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study

National cohort data collected during the coronavirus disease 2019 (COVID-19) delta and omicron periods in Korea revealed a lower risk of severe infection in recipients of three doses of the COVID-19 vaccine (adjusted odds ratio [aOR], 0.05–0.08). The risk of death was reduced during the omicron per...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yoo-Yeon, Choe, Young June, Kim, Jia, Kim, Ryu Kyung, Jang, Eun Jung, Lee, Hyeryeon, Yi, Seonju, Lee, Sangwon, Park, Young-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027545/
https://www.ncbi.nlm.nih.gov/pubmed/36942395
http://dx.doi.org/10.3346/jkms.2023.38.e87
_version_ 1784909727074877440
author Kim, Yoo-Yeon
Choe, Young June
Kim, Jia
Kim, Ryu Kyung
Jang, Eun Jung
Lee, Hyeryeon
Yi, Seonju
Lee, Sangwon
Park, Young-Joon
author_facet Kim, Yoo-Yeon
Choe, Young June
Kim, Jia
Kim, Ryu Kyung
Jang, Eun Jung
Lee, Hyeryeon
Yi, Seonju
Lee, Sangwon
Park, Young-Joon
author_sort Kim, Yoo-Yeon
collection PubMed
description National cohort data collected during the coronavirus disease 2019 (COVID-19) delta and omicron periods in Korea revealed a lower risk of severe infection in recipients of three doses of the COVID-19 vaccine (adjusted odds ratio [aOR], 0.05–0.08). The risk of death was reduced during the omicron period compared to the delta period (aOR, 0.75; 95% confidence interval, 0.67–0.84).
format Online
Article
Text
id pubmed-10027545
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-100275452023-03-22 Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study Kim, Yoo-Yeon Choe, Young June Kim, Jia Kim, Ryu Kyung Jang, Eun Jung Lee, Hyeryeon Yi, Seonju Lee, Sangwon Park, Young-Joon J Korean Med Sci Brief Communication National cohort data collected during the coronavirus disease 2019 (COVID-19) delta and omicron periods in Korea revealed a lower risk of severe infection in recipients of three doses of the COVID-19 vaccine (adjusted odds ratio [aOR], 0.05–0.08). The risk of death was reduced during the omicron period compared to the delta period (aOR, 0.75; 95% confidence interval, 0.67–0.84). The Korean Academy of Medical Sciences 2023-03-08 /pmc/articles/PMC10027545/ /pubmed/36942395 http://dx.doi.org/10.3346/jkms.2023.38.e87 Text en © 2023 The Korean Academy of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communication
Kim, Yoo-Yeon
Choe, Young June
Kim, Jia
Kim, Ryu Kyung
Jang, Eun Jung
Lee, Hyeryeon
Yi, Seonju
Lee, Sangwon
Park, Young-Joon
Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
title Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
title_full Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
title_fullStr Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
title_full_unstemmed Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
title_short Vaccine Effectiveness Against Severe Disease and Death for Patients With COVID-19 During the Delta-Dominant and Omicron-Emerging Periods: A K-COVE Study
title_sort vaccine effectiveness against severe disease and death for patients with covid-19 during the delta-dominant and omicron-emerging periods: a k-cove study
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027545/
https://www.ncbi.nlm.nih.gov/pubmed/36942395
http://dx.doi.org/10.3346/jkms.2023.38.e87
work_keys_str_mv AT kimyooyeon vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy
AT choeyoungjune vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy
AT kimjia vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy
AT kimryukyung vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy
AT jangeunjung vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy
AT leehyeryeon vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy
AT yiseonju vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy
AT leesangwon vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy
AT parkyoungjoon vaccineeffectivenessagainstseverediseaseanddeathforpatientswithcovid19duringthedeltadominantandomicronemergingperiodsakcovestudy

Ejemplares similares